SANBIO COMPANY LIMITED March 11, 2022 | |
Company name: | SanBio Co., Ltd. |
Representative: | Keita Mori, Representative Director |
and President | |
(TSE Mothers Code: 4592) | |
Contact: | Yoshihiro Kakutani, Corporate Officer |
of Management Administration | |
(TEL. +81-3-6264-3481) |
Recording of Non-Operating Expenses (Financing Expenses)
SanBio Company Limited (the "Company") hereby announces the recording of non-operating expenses (financing expenses) in the fiscal year ended January 31, 2022 (February 1, 2021-January 31, 2022).
1. Overview of non-operating expenses (financing expenses)
The Company recorded financing expenses of 10 million yen as non-operating expenses in the fiscal year ended January 31, 2022. These expenses mainly came from fees related to the committed credit line agreement the Company entered into with three banks.
2. Impact on earnings performance
Regarding the impact of the non-operating expenses (financing expenses) on the Company's earnings performance, please see the "Consolidated Financial Results for the Fiscal Year Ended January 31, 2022 (Japanese GAAP)" released March 11, 2022.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
SanBio Co. Ltd. published this content on 23 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 March 2022 07:03:02 UTC.
